TipRanks
Tilray (TLRY)
NASDAQ:TLRY
US Market
TLRY
Tilray
RESEARCH TOOLSreports
Want to see TLRY full AI Analyst Report?

Tilray (TLRY) Stock Forecast & Price Target

11,952 Followers
See the Price Targets and Ratings of:

TLRY Analyst Ratings

Moderate Buy
6Ratings
Moderate Buy
2 Buy
4 Hold
0 Sell
Based on 6 analysts giving stock ratings to
Tilray
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

TLRY Stock 12 Month Forecast

Average Price Target

$5.05
▲(8.90% Upside)
Based on 6 Wall Street analysts offering 12 month price targets for Tilray in the last 3 months. The average price target is $5.05 with a high forecast of $10.00 and a low forecast of $2.82. The average price target represents a 8.90% change from the last price of $4.64.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"$1","5":"$5","9":"$9","13":"$13","17":"$17"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":10,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$10.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5.053038666666667,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$5.05</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.818232,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$2.82</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,5,9,13,17],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.57,4.064615384615385,4.559230769230769,5.053846153846154,5.548461538461538,6.043076923076923,6.537692307692307,7.0323076923076915,7.526923076923076,8.02153846153846,8.516153846153845,9.01076923076923,9.505384615384616,{"y":10,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.57,3.6840798974358973,3.7981597948717947,3.912239692307692,4.02631958974359,4.140399487179487,4.254479384615385,4.368559282051282,4.48263917948718,4.596719076923077,4.710798974358974,4.824878871794872,4.938958769230769,{"y":5.053038666666667,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.57,3.512171692307692,3.4543433846153846,3.3965150769230767,3.3386867692307693,3.2808584615384615,3.2230301538461537,3.1652018461538463,3.1073735384615384,3.0495452307692306,2.991716923076923,2.9338886153846153,2.876060307692308,{"y":2.818232,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":16.55,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.4,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.824,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.03,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.44,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.6,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.14,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.16,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.49,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.43,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.54,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.5,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.57,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$10.00Average Price Target$5.05Lowest Price Target$2.82
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Canaccord Genuity Analyst forecast on TLRY
Kenric Tyghe
Canaccord Genuity
Canaccord Genuity
$4.5→$4
Hold
-13.79%
Downside
Reiterated
10/09/26
Analysts Offer Insights on Healthcare Companies: Tilray (NASDAQ: TLRY) and Hinge Health, Inc. Class A (NYSE: HNGE)
TD Cowen Analyst forecast on TLRY
Derek Lessard
TD Cowen
TD Cowen
$4.5
Buy
-3.02%
Downside
Assigned
10/09/26
TD Cowen Sticks to Their Buy Rating for Tilray (TLRY)
ATB Cormark Capital Markets Analyst forecast on TLRY
Frederico Gomes
ATB Cormark Capital Markets
ATB Cormark Capital Markets
$6→$5
Hold
7.76%
Upside
Reiterated
10/09/26
Analysts Offer Insights on Healthcare Companies: United Therapeutics (NASDAQ: UTHR), Tilray (NASDAQ: TLRY) and Viatris (NASDAQ: VTRS)
Roth MKM Analyst forecast on TLRY
Bill Kirk
Roth MKM
Roth MKM
$10
Buy
115.52%
Upside
Reiterated
10/06/26
Roth MKM Reaffirms Their Buy Rating on Tilray (TLRY)
Alliance Global Partners Analyst forecast on TLRY
Aaron Grey
Alliance Global Partners
Alliance Global Partners
$5→$4
Hold
-13.79%
Downside
Reiterated
10/05/26
Analysts Conflicted on These Healthcare Names: Alignment Healthcare (NASDAQ: ALHC), Tilray (NASDAQ: TLRY) and Fractyl Health, Inc. (NASDAQ: GUTS)
Haywood Analyst forecast on TLRY
Neal Gilmer
Haywood
Haywood
$3.52→$2.82
Hold
-39.26%
Downside
Reiterated
10/02/26
Analysts Offer Insights on Healthcare Companies: Pfizer (NYSE: PFE) and Tilray (NASDAQ: TLRY)
Bernstein Analyst forecast on TLRY
Unknown Analyst
Bernstein
Not Ranked
Bernstein
$10→$6.5
Hold
40.09%
Upside
Reiterated
06/25/26
Bernstein Reaffirms Their Hold Rating on Tilray (TLRY)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Canaccord Genuity Analyst forecast on TLRY
Kenric Tyghe
Canaccord Genuity
Canaccord Genuity
$4.5→$4
Hold
-13.79%
Downside
Reiterated
10/09/26
Analysts Offer Insights on Healthcare Companies: Tilray (NASDAQ: TLRY) and Hinge Health, Inc. Class A (NYSE: HNGE)
TD Cowen Analyst forecast on TLRY
Derek Lessard
TD Cowen
TD Cowen
$4.5
Buy
-3.02%
Downside
Assigned
10/09/26
TD Cowen Sticks to Their Buy Rating for Tilray (TLRY)
ATB Cormark Capital Markets Analyst forecast on TLRY
Frederico Gomes
ATB Cormark Capital Markets
ATB Cormark Capital Markets
$6→$5
Hold
7.76%
Upside
Reiterated
10/09/26
Analysts Offer Insights on Healthcare Companies: United Therapeutics (NASDAQ: UTHR), Tilray (NASDAQ: TLRY) and Viatris (NASDAQ: VTRS)
Roth MKM Analyst forecast on TLRY
Bill Kirk
Roth MKM
Roth MKM
$10
Buy
115.52%
Upside
Reiterated
10/06/26
Roth MKM Reaffirms Their Buy Rating on Tilray (TLRY)
Alliance Global Partners Analyst forecast on TLRY
Aaron Grey
Alliance Global Partners
Alliance Global Partners
$5→$4
Hold
-13.79%
Downside
Reiterated
10/05/26
Analysts Conflicted on These Healthcare Names: Alignment Healthcare (NASDAQ: ALHC), Tilray (NASDAQ: TLRY) and Fractyl Health, Inc. (NASDAQ: GUTS)
Haywood Analyst forecast on TLRY
Neal Gilmer
Haywood
Haywood
$3.52→$2.82
Hold
-39.26%
Downside
Reiterated
10/02/26
Analysts Offer Insights on Healthcare Companies: Pfizer (NYSE: PFE) and Tilray (NASDAQ: TLRY)
Bernstein Analyst forecast on TLRY
Unknown Analyst
Bernstein
Not Ranked
Bernstein
$10→$6.5
Hold
40.09%
Upside
Reiterated
06/25/26
Bernstein Reaffirms Their Hold Rating on Tilray (TLRY)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
OVIDOvid Therapeutics
AXGNAxoGen
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings
REPLReplimune Group
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Tilray

3 Months
Derek LessardTD Cowen
Success Rate
0/2 ratings generated profit
0%
Average Return
-21.45%
Copying Derek Lessard's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -21.45% per trade.
1 Year
Derek LessardTD Cowen
Success Rate
0/2 ratings generated profit
0%
Average Return
-21.45%
Copying Derek Lessard's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -21.45% per trade.
2 Years
Derek LessardTD Cowen
Success Rate
0/2 ratings generated profit
0%
Average Return
-21.45%
Copying Derek Lessard's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -21.45% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TLRY Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
1
0
0
0
1
Buy
0
2
2
2
2
Hold
5
4
3
3
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
6
5
5
8
In the current month, TLRY has received 3 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. TLRY average Analyst price target in the past 3 months is 5.05.
Each month's total comprises the sum of three months' worth of ratings.

TLRY Financial Forecast

TLRY Earnings Forecast

Next quarter’s earnings estimate for TLRY is -$0.16 with a range of -$0.21 to -$0.06. The previous quarter’s EPS was -$0.32. TLRY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year TLRY has Performed in-line its overall industry.
Next quarter’s earnings estimate for TLRY is -$0.16 with a range of -$0.21 to -$0.06. The previous quarter’s EPS was -$0.32. TLRY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year TLRY has Performed in-line its overall industry.

TLRY Sales Forecast

Next quarter’s sales forecast for TLRY is $265.01M with a range of $245.60M to $272.00M. The previous quarter’s sales results were $257.15M. TLRY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year TLRY has Performed in-line its overall industry.
Next quarter’s sales forecast for TLRY is $265.01M with a range of $245.60M to $272.00M. The previous quarter’s sales results were $257.15M. TLRY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year TLRY has Performed in-line its overall industry.

TLRY Stock Forecast FAQ

What is TLRY’s average 12-month price target, according to analysts?
Based on analyst ratings, Tilray’s 12-month average price target is 5.05.
    What is TLRY’s upside potential, based on the analysts’ average price target?
    Tilray has 8.90% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is TLRY a Buy, Sell or Hold?
          Tilray has a consensus rating of Moderate Buy which is based on 2 buy ratings, 4 hold ratings and 0 sell ratings.
            What is Tilray’s price target?
            The average price target for Tilray is 5.05. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $10.00 ,the lowest forecast is $2.82. The average price target represents 8.90% Increase from the current price of $4.64.
              What do analysts say about Tilray?
              Tilray’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 6 Wall Streets Analysts.
                How can I buy shares of TLRY?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.